Trials / Conditions / Idiopathic Restless Legs Syndrome

Idiopathic Restless Legs Syndrome

7 registered clinical trials studyying Idiopathic Restless Legs Syndrome.

Status	Trial	Sponsor	Phase
Completed	Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise NCT01113710	UCB Pharma	—
Completed	Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) NCT01084551	Otsuka Pharmaceutical Co., Ltd.	Phase 3
Completed	Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients NCT00806026	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome NCT01562743	Otsuka Pharmaceutical Co., Ltd.	Phase 2
Completed	A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients NCT00666965	Otsuka Pharmaceutical Co., Ltd.	Phase 2
Completed	A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS NCT00390689	Boehringer Ingelheim	Phase 3
Completed	Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects NCT00498108	UCB Pharma	Phase 3